nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ABCA5—eye—age related macular degeneration	0.0503	0.161	CbGeAlD
Tacrolimus—ABCA5—retina—age related macular degeneration	0.0498	0.159	CbGeAlD
Tacrolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFBR1—age related macular degeneration	0.0405	0.0588	CbGpPWpGaD
Tacrolimus—PPP3CA—retina—age related macular degeneration	0.0337	0.108	CbGeAlD
Tacrolimus—PPP3CA—connective tissue—age related macular degeneration	0.0327	0.105	CbGeAlD
Tacrolimus—PPP3CA—Amyotrophic lateral sclerosis (ALS)—CST3—age related macular degeneration	0.0291	0.0423	CbGpPWpGaD
Tacrolimus—FKBP1A—ALK1 signaling events—TGFBR1—age related macular degeneration	0.0274	0.0399	CbGpPWpGaD
Tacrolimus—MTOR—eye—age related macular degeneration	0.0251	0.0803	CbGeAlD
Tacrolimus—MTOR—retina—age related macular degeneration	0.0249	0.0796	CbGeAlD
Tacrolimus—MTOR—connective tissue—age related macular degeneration	0.0242	0.0773	CbGeAlD
Tacrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFBR1—age related macular degeneration	0.0232	0.0338	CbGpPWpGaD
Tacrolimus—FKBP1A—eye—age related macular degeneration	0.0226	0.0722	CbGeAlD
Tacrolimus—FKBP1A—retina—age related macular degeneration	0.0224	0.0716	CbGeAlD
Tacrolimus—FKBP1A—connective tissue—age related macular degeneration	0.0217	0.0696	CbGeAlD
Tacrolimus—PPP3CA—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.0194	0.0283	CbGpPWpGaD
Tacrolimus—MTOR—LKB1 signaling events—MAP2—age related macular degeneration	0.0188	0.0274	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta receptor signaling—TGFBR1—age related macular degeneration	0.0158	0.0229	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—TGFBR1—age related macular degeneration	0.0153	0.0222	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—TIMP3—age related macular degeneration	0.0152	0.0221	CbGpPWpGaD
Tacrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR1—age related macular degeneration	0.0138	0.02	CbGpPWpGaD
Tacrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFBR1—age related macular degeneration	0.0124	0.0181	CbGpPWpGaD
Tacrolimus—ALB—HDL-mediated lipid transport—CETP—age related macular degeneration	0.0119	0.0173	CbGpPWpGaD
Tacrolimus—ABCB1—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.0118	0.0171	CbGpPWpGaD
Tacrolimus—ABCB1—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.0105	0.0152	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—COL10A1—age related macular degeneration	0.0103	0.015	CbGpPWpGaD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.00847	0.0123	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.00795	0.0116	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—SERPING1—age related macular degeneration	0.00784	0.0114	CbGpPWpGaD
Tacrolimus—PPP3CA—Alzheimers Disease—APOE—age related macular degeneration	0.0078	0.0113	CbGpPWpGaD
Tacrolimus—MTOR—RANKL/RANK Signaling Pathway—SQSTM1—age related macular degeneration	0.00768	0.0112	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—C9—age related macular degeneration	0.00753	0.0109	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.00747	0.0109	CbGpPWpGaD
Tacrolimus—ALB—Lipoprotein metabolism—LIPC—age related macular degeneration	0.00709	0.0103	CbGpPWpGaD
Tacrolimus—ALB—Lipoprotein metabolism—CETP—age related macular degeneration	0.00684	0.00994	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.00673	0.00978	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CFI—age related macular degeneration	0.00653	0.00949	CbGpPWpGaD
Tacrolimus—ALB—HDL-mediated lipid transport—APOE—age related macular degeneration	0.00631	0.00918	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.0062	0.00901	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CFHR3—age related macular degeneration	0.00607	0.00883	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00556	0.00809	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—TLR4—age related macular degeneration	0.00554	0.00806	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—C2—age related macular degeneration	0.00541	0.00787	CbGpPWpGaD
Tacrolimus—ABCB1—retina—age related macular degeneration	0.00517	0.0166	CbGeAlD
Tacrolimus—PPP3CA—Spinal Cord Injury—CCL2—age related macular degeneration	0.00475	0.00691	CbGpPWpGaD
Tacrolimus—ALB—Lipid and lipoprotein metabolism—LIPC—age related macular degeneration	0.00471	0.00685	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NMNAT1—age related macular degeneration	0.00463	0.00674	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—RDH8—age related macular degeneration	0.00463	0.00674	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—SQSTM1—age related macular degeneration	0.00458	0.00666	CbGpPWpGaD
Tacrolimus—ALB—Lipid and lipoprotein metabolism—CETP—age related macular degeneration	0.00454	0.00661	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CFH—age related macular degeneration	0.00452	0.00658	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CFB—age related macular degeneration	0.00439	0.00638	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—C9—age related macular degeneration	0.00438	0.00638	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—TLR4—age related macular degeneration	0.0043	0.00625	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—RPE65—age related macular degeneration	0.00405	0.00589	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CFI—age related macular degeneration	0.0038	0.00553	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.00378	0.00549	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—CCL2—age related macular degeneration	0.00369	0.00536	CbGpPWpGaD
Tacrolimus—ALB—Lipoprotein metabolism—APOE—age related macular degeneration	0.00363	0.00527	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—RDH8—age related macular degeneration	0.00359	0.00522	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NMNAT1—age related macular degeneration	0.00359	0.00522	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.00356	0.00517	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CFHR3—age related macular degeneration	0.00353	0.00514	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00348	0.00506	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—RHO—age related macular degeneration	0.00337	0.00489	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—CCL2—age related macular degeneration	0.00334	0.00486	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—C9—age related macular degeneration	0.00328	0.00477	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—ABCA4—age related macular degeneration	0.00326	0.00475	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RDH8—age related macular degeneration	0.00324	0.00472	CbGpPWpGaD
Tacrolimus—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—age related macular degeneration	0.0032	0.00465	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—C2—age related macular degeneration	0.00315	0.00458	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—RPE65—age related macular degeneration	0.00314	0.00457	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CFI—age related macular degeneration	0.00285	0.00414	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—RHO—age related macular degeneration	0.00284	0.00413	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RPE65—age related macular degeneration	0.00283	0.00412	CbGpPWpGaD
Tacrolimus—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—age related macular degeneration	0.00282	0.00411	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CFHR3—age related macular degeneration	0.00265	0.00385	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CFH—age related macular degeneration	0.00264	0.00383	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—KDR—age related macular degeneration	0.00261	0.0038	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CFB—age related macular degeneration	0.00256	0.00372	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—ABCA4—age related macular degeneration	0.00253	0.00368	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RDH8—age related macular degeneration	0.00251	0.00366	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—KDR—age related macular degeneration	0.00247	0.00359	CbGpPWpGaD
Tacrolimus—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00246	0.00358	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00242	0.00352	CbGpPWpGaD
Tacrolimus—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.00241	0.0035	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00237	0.00345	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—C2—age related macular degeneration	0.00236	0.00343	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ABCA4—age related macular degeneration	0.00229	0.00332	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—RHO—age related macular degeneration	0.0022	0.0032	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RPE65—age related macular degeneration	0.0022	0.0032	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—VEGFA—age related macular degeneration	0.00215	0.00312	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—SQSTM1—age related macular degeneration	0.00205	0.00299	CbGpPWpGaD
Tacrolimus—MTOR—Disease—RDH8—age related macular degeneration	0.00202	0.00294	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NMNAT1—age related macular degeneration	0.00202	0.00294	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00199	0.0029	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RHO—age related macular degeneration	0.00199	0.00289	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CFH—age related macular degeneration	0.00197	0.00287	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—CRP—age related macular degeneration	0.00197	0.00287	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CFB—age related macular degeneration	0.00191	0.00278	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—C9—age related macular degeneration	0.00191	0.00278	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—F13B—age related macular degeneration	0.00191	0.00277	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—CD36—age related macular degeneration	0.00187	0.00273	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CD36—age related macular degeneration	0.0018	0.00262	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SERPING1—age related macular degeneration	0.00179	0.00261	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00179	0.0026	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CST3—age related macular degeneration	0.00177	0.00258	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00177	0.00258	CbGpPWpGaD
Tacrolimus—MTOR—Disease—RPE65—age related macular degeneration	0.00177	0.00257	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—C3—age related macular degeneration	0.00171	0.00248	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CFI—age related macular degeneration	0.00166	0.00241	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00163	0.00237	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CRP—age related macular degeneration	0.00162	0.00236	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.00162	0.00236	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00161	0.00234	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFBR1—age related macular degeneration	0.00159	0.00232	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.00157	0.00229	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00157	0.00228	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—SQSTM1—age related macular degeneration	0.00156	0.00228	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—TLR4—age related macular degeneration	0.00156	0.00226	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—RAD51B—age related macular degeneration	0.00155	0.00226	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RHO—age related macular degeneration	0.00154	0.00224	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CFHR3—age related macular degeneration	0.00154	0.00224	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.0015	0.00218	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.00144	0.0021	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.00144	0.00209	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ABCA4—age related macular degeneration	0.00142	0.00207	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RDH8—age related macular degeneration	0.00141	0.00206	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0014	0.00204	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CST3—age related macular degeneration	0.00138	0.002	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—C2—age related macular degeneration	0.00137	0.002	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—VEGFA—age related macular degeneration	0.00136	0.00198	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00135	0.00196	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NMNAT1—age related macular degeneration	0.00133	0.00194	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00129	0.00187	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00125	0.00182	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00125	0.00182	CbGpPWpGaD
Tacrolimus—MTOR—Disease—RHO—age related macular degeneration	0.00124	0.0018	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RPE65—age related macular degeneration	0.00124	0.0018	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFBR1—age related macular degeneration	0.00124	0.0018	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00123	0.00179	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ELOVL4—age related macular degeneration	0.00117	0.0017	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CFH—age related macular degeneration	0.00115	0.00167	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFBR1—age related macular degeneration	0.00112	0.00162	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CFB—age related macular degeneration	0.00111	0.00162	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0011	0.00159	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0011	0.00159	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.00109	0.00159	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—C3—age related macular degeneration	0.00109	0.00158	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD36—age related macular degeneration	0.00105	0.00153	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SQSTM1—age related macular degeneration	0.00101	0.00147	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ABCA4—age related macular degeneration	0.000996	0.00145	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—C3—age related macular degeneration	0.000994	0.00145	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	0.000965	0.0014	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CRP—age related macular degeneration	0.000946	0.00138	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SLC16A8—age related macular degeneration	0.000941	0.00137	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.000912	0.00133	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—TLR4—age related macular degeneration	0.000907	0.00132	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.000893	0.0013	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RHO—age related macular degeneration	0.000867	0.00126	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000865	0.00126	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—APOE—age related macular degeneration	0.000854	0.00124	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CCL2—age related macular degeneration	0.000851	0.00124	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00085	0.00124	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	0.000843	0.00123	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.000832	0.00121	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NMNAT1—age related macular degeneration	0.000831	0.00121	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.00079	0.00115	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD36—age related macular degeneration	0.000785	0.00114	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000784	0.00114	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CST3—age related macular degeneration	0.000774	0.00113	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD36—age related macular degeneration	0.000754	0.0011	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—C3—age related macular degeneration	0.000744	0.00108	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.000728	0.00106	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ELOVL4—age related macular degeneration	0.000726	0.00106	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—C3—age related macular degeneration	0.000715	0.00104	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CRP—age related macular degeneration	0.000708	0.00103	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—VEGFA—age related macular degeneration	0.000699	0.00102	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFBR1—age related macular degeneration	0.000695	0.00101	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—SQSTM1—age related macular degeneration	0.000682	0.000992	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.00068	0.000989	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—TLR4—age related macular degeneration	0.000679	0.000987	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000673	0.000979	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—APOE—age related macular degeneration	0.000663	0.000964	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000649	0.000944	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—C3—age related macular degeneration	0.000643	0.000935	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000636	0.000926	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000617	0.000898	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—APOE—age related macular degeneration	0.000598	0.00087	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—KDR—age related macular degeneration	0.000586	0.000853	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC16A8—age related macular degeneration	0.000586	0.000852	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000541	0.000787	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000513	0.000746	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCL2—age related macular degeneration	0.000503	0.000731	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—C3—age related macular degeneration	0.000498	0.000725	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFBR1—age related macular degeneration	0.000487	0.000708	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—LIPC—age related macular degeneration	0.000481	0.0007	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CETP—age related macular degeneration	0.000465	0.000676	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APOE—age related macular degeneration	0.000464	0.000675	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD36—age related macular degeneration	0.000457	0.000665	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—KDR—age related macular degeneration	0.000455	0.000661	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000449	0.000652	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SQSTM1—age related macular degeneration	0.000441	0.000642	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—C3—age related macular degeneration	0.000434	0.00063	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—CD36—age related macular degeneration	0.000429	0.000623	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—age related macular degeneration	0.000412	0.0006	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000396	0.000576	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR4—age related macular degeneration	0.000395	0.000575	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000392	0.00057	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00039	0.000568	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCL2—age related macular degeneration	0.00039	0.000567	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00039	0.000567	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APOE—age related macular degeneration	0.000373	0.000542	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000348	0.000506	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000344	0.000501	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CETP—age related macular degeneration	0.000336	0.000488	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VEGFA—age related macular degeneration	0.000323	0.00047	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000316	0.00046	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—LIPC—age related macular degeneration	0.0003	0.000436	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CETP—age related macular degeneration	0.000289	0.000421	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—C3—age related macular degeneration	0.00028	0.000408	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CD36—age related macular degeneration	0.000279	0.000406	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000263	0.000382	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOE—age related macular degeneration	0.000261	0.00038	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KDR—age related macular degeneration	0.000256	0.000372	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CETP—age related macular degeneration	0.000253	0.000369	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—age related macular degeneration	0.00025	0.000364	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOE—age related macular degeneration	0.000246	0.000358	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL2—age related macular degeneration	0.000219	0.000319	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000204	0.000297	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CD36—age related macular degeneration	0.000202	0.000294	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOE—age related macular degeneration	0.000178	0.000259	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CD36—age related macular degeneration	0.000174	0.000253	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000162	0.000235	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000156	0.000227	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOE—age related macular degeneration	0.000153	0.000223	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CD36—age related macular degeneration	0.000152	0.000221	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—age related macular degeneration	0.000141	0.000205	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOE—age related macular degeneration	0.000134	0.000195	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CD36—age related macular degeneration	9.38e-05	0.000136	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOE—age related macular degeneration	8.28e-05	0.00012	CbGpPWpGaD
